Abstract:Introduction Tacrolimus is a mainstay of immunosuppression after solid organ transplant to prevent organ rejection. While it has several well-established toxicities including kidney injury and central nervous system disturbances, its association with diffuse lung injury is rare. Case Description A 52-year-old man who underwent heart transplantation for genetic cardiomyopathy presented to the clinic three weeks post-transplant with subjective fever, night sweats, and exertional dyspnea. He was maintained on standard immunosuppression with tacrolimus, mycophenolate mofetil, and prednisone taper. Extensive workup for bacterial, viral, and fungal infections was unremarkable. Serial surveillance protocol right heart catheterizations showed normal filling pressures and hemodynamics, with no evidence of rejection on endomyocardial biopsies. CT chest, abdomen, and pelvis (Image A) at eight weeks since the first reported symptom onset was only notable for a new 5 mm lung nodule. The patient had gradually progressive dyspnea and hypoxia for which he underwent serial imaging. At twelve weeks, CT chest showed progression to multiple bilateral pleural-based lung nodules measuring up to 8mm. FDG-PET/CT (Image B) showed low-level activity and FDG uptake in some nodules concerning for malignancy or atypical infection. Given the peripheral location of the nodules, video-assisted thoracoscopic surgery and wedge resection was performed. Histopathology revealed nodules with abscess formation and fibrin deposits with no evidence of malignancy, granuloma, or infection. At six months, CT chest (Image C) revealed new diffuse bilateral ground glass opacities. Bronchoalveolar lavage showed no evidence of atypical microbial growth. After extensive discussions with pulmonology and infectious disease consultants, drug toxicity secondary to Tacrolimus was presumed to be the culprit. He was switched to Cyclosporine. After four weeks of Tacrolimus discontinuation, he had resolution of symptoms, and repeat imaging (Image D) demonstrated complete resolution of lung opacities with decreasing size of nodules. Tacrolimus was discontinued indefinitely. Conclusion Though described in case series in patients with rheumatoid arthritis, to the best of our knowledge, this is the first reported case of Tacrolimus-associated diffuse lung injury after a cardiac transplant. Extrapolating from data for rheumatoid arthritis, the lung injury is hypothesized to be a result of inflammatory cytokine-mediated endothelial injury. This could potentially explain the FDG uptake seen in our patient. Tacrolimus-associated diffuse lung injury, although rare, should be considered in patients who present with diffuse infiltrates, after appropriate workup to exclude other processes including malignancy and infection.

Acute left ventricular failure induced by cyclosporine and tacrolimus in a patient with dermatomyositis

New-Onset Diabetes Mellitus in Patients with Idiopathic Membranous Nephropathy Undergoing Tacrolimus and Low-Dose Corticosteroid Therapy.

The Efficacy and Safety of Tacrolimus Monotherapy in Adult-Onset Nephrotic Syndrome Caused by Idiopathic Membranous Nephropathy

Tacrolimus As a Steroid-Sparing Agent for Adults with Steroid-Dependent Minimal Change Nephrotic Syndrome

Tacrolimus Combined with Corticosteroids in Treatment of Nephrotic Idiopathic Membranous Nephropathy: A Multicenter Randomized Controlled Trial

Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.

Tacrolimus-Induced Diffuse Lung Injury

Tacrolimus versus cyclophosphamide as treatment for diffuse proliferative or membranous lupus nephritis: a non-randomized prospective cohort study.

Tacrolimus Causes Hypertension by Increasing Vascular Contractility via RhoA (Ras Homolog Family Member A)/ROCK (Rho-Associated Protein Kinase) Pathway in Mice

Early Initiation of Tacrolimus or Cyclophosphamide Therapy for Idiopathic Membranous Nephropathy with Severe Proteinuria.

Cefadroxil Tablets Induced-Drug Hypersensitivity Syndrome Complicated with Acute Myocarditis and Death

Tacrolimus As Rescue Therapy for Adult-Onset Refractory Minimal Change Nephrotic Syndrome with Reversible Acute Renal Failure.

Tacrolimus-Induced Recurrent Acute Coronary Syndrome Due to an Unknown Mechanism

A case report of tacrolimus-related hypertrophic cardiomyopathy

Case Report: Extracorporeal Membrane Oxgenation for Rapidly Progressive Interstitial Lung Disease Associated with Clinically Amyopathic Dermatomyositis in a Post-partum Woman.

Case report: Successful treatment of acute generalized pustular psoriasis with multiple comorbidities with oral tacrolimus

Effectiveness and Safety of 24 Months' Treatment with Tacrolimus Combined with Corticosteroids in Patients with Idiopathic Membranous Nephropathy

Tacrolimus causes acute renal failure in the treatment of nephrotic syndrome in children:a report of 3 cases

Drug Reaction With Eosinophilia and Systemic Symptoms-Associated Perimyocarditis After Initiation of Anti-tuberculosis Therapy: A Case Report

Treatment of Idiopathic Orbital Myositis with Frequent Relapses: First Case with Tacrolimus and Review of Literature

Tacrolimus Monotherapy after Intravenous Methylprednisolone in Adults with Minimal Change Nephrotic Syndrome.